|
CRP group (n=73)
|
Communication group (n=73)
|
Combined group (n=83)
|
---|
|
Baseline (mean (SD))
|
Follow-up (mean (SD))
|
Effect size (Cohen’s d)a
|
Baseline (mean (SD))
|
Follow-up (mean (SD))
|
Effect size (Cohen’s d)
|
Baseline (mean (SD))
|
Follow-up (mean (SD))
|
Effect size (Cohen’s d)
|
---|
Importance of reducing prescribing
|
6.03b (1.27)
|
6.22 (1.00)
|
.15
|
5.85 (1.43)
|
6.34 (0.89)
|
.35**
|
5.90 (1.08)
|
6.25 (1.05)
|
.27*
|
Risks of reducing prescribing
|
4.37 (1.56)
|
4.88 (1.37)
|
.31*
|
4.81 (1.61)
|
5.16 (1.45)
|
.19
|
4.33 (1.47)
|
4.76 (1.50)
|
.23*
|
Risk to relationship with patients
|
4.49 (1.62)
|
4.63 (1.58)
|
.08
|
4.74 (1.80)
|
4.89 (1.61)
|
.08
|
4.76 (1.41)
|
5.12 (1.33)
|
.25*
|
Confidence to reduce prescribing
|
4.89 (1.49)
|
4.64 (1.49)
|
-.13
|
4.71 (1.79)
|
5.12 (1.70)
|
.21
|
4.86 (1.50)
|
5.28 (1.35)
|
.25*
|
- *p < .05, **p < .01 for change in mean score (paired samples t-test).
-
aEffect size (d) reported such that positive value represents positive change.
-
bScores are on a scale from 1 (disagree strongly) to 7 (agree strongly).